HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Des R Richardson Selected Research

Proto-Oncogene Proteins c-cbl

10/2021The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Des R Richardson Research Topics

Disease

131Neoplasms (Cancer)
01/2022 - 01/2002
41Neoplasm Metastasis (Metastasis)
12/2021 - 01/2005
15Friedreich Ataxia (Friedreich's Ataxia)
10/2021 - 05/2002
15Iron Overload
01/2021 - 04/2003
12Hypoxia (Hypoxemia)
01/2020 - 05/2003
10Prostatic Neoplasms (Prostate Cancer)
12/2021 - 10/2004
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2008
7Alzheimer Disease (Alzheimer's Disease)
05/2018 - 03/2004
7Melanoma (Melanoma, Malignant)
03/2018 - 09/2002
6Cardiomyopathies (Cardiomyopathy)
10/2021 - 04/2008
5Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 06/2010
5Breast Neoplasms (Breast Cancer)
01/2021 - 02/2012
5Iron Deficiencies
01/2016 - 05/2007
4Parkinson Disease (Parkinson's Disease)
02/2022 - 03/2004
4Neuroblastoma
11/2021 - 01/2002
3Cardiotoxicity
11/2021 - 01/2009
3Malaria
10/2019 - 03/2004
3Inflammation (Inflammations)
01/2017 - 06/2013
3Leukemia
01/2015 - 01/2002
3Adenocarcinoma
01/2015 - 10/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
04/2010 - 03/2004
3beta-Thalassemia (Cooley's Anemia)
02/2010 - 07/2003
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2021 - 01/2020
2Carcinogenesis
10/2020 - 01/2017
2Colorectal Neoplasms (Colorectal Cancer)
12/2016 - 10/2015
2Colonic Neoplasms (Colon Cancer)
05/2016 - 07/2014
2Ataxia (Dyssynergia)
01/2016 - 03/2005
2Carcinoma (Carcinomatosis)
01/2015 - 01/2013
2Methemoglobinemia
03/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

90IronIBA
02/2022 - 01/2002
64Chelating AgentsIBA
09/2020 - 01/2002
47ThiosemicarbazonesIBA
01/2022 - 07/2002
31di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazoneIBA
01/2022 - 09/2004
24Proteins (Proteins, Gene)FDA Link
10/2021 - 04/2002
17CopperIBA
10/2019 - 12/2006
15Pharmaceutical PreparationsIBA
04/2019 - 03/2007
13LigandsIBA
11/2021 - 01/2005
13Deferoxamine (Desferal)FDA LinkGeneric
11/2021 - 01/2003
13FrataxinIBA
10/2021 - 05/2002
13MetalsIBA
09/2020 - 03/2004
10Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 12/2006
7di-2-pyridylketone 4- cyclohexyl- 4- methyl- 3- thiosemicarbazoneIBA
04/2019 - 10/2011
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2014
7HydrazonesIBA
05/2018 - 03/2007
7Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2018 - 04/2015
6Biological ProductsIBA
12/2016 - 08/2007
5CateninsIBA
01/2022 - 09/2013
5Phosphotransferases (Kinase)IBA
10/2021 - 09/2013
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 05/2003
5Transferrin (beta 2 Transferrin)IBA
01/2016 - 09/2002
4Mitochondrial Proteins (Mitochondrial Protein)IBA
10/2021 - 02/2010
4GemcitabineFDA Link
01/2021 - 10/2011
4Ferritins (Ferritin)IBA
01/2021 - 10/2004
4Messenger RNA (mRNA)IBA
10/2020 - 12/2010
4IonsIBA
01/2020 - 03/2004
4ErbB Receptors (EGF Receptor)IBA
08/2019 - 01/2016
4Cyclin D1IBA
10/2015 - 01/2005
42-benzoylpyridineIBA
02/2013 - 01/2011
3AndrogensIBA
12/2021 - 12/2006
3tyrosine receptor (receptor, tyrosine)IBA
10/2021 - 11/2015
3LipidsIBA
01/2021 - 01/2014
3Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 01/2016
3NF-kappa B (NF-kB)IBA
10/2019 - 01/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2016 - 10/2002
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2016 - 03/2009
3DNA (Deoxyribonucleic Acid)IBA
10/2015 - 04/2003
3Transforming Growth Factor beta (TGF-beta)IBA
01/2013 - 01/2009
2CytokinesIBA
01/2022 - 01/2022
2Androgen Receptors (Androgen Receptor)IBA
12/2021 - 01/2020
2MM Form Creatine KinaseIBA
10/2021 - 07/2008
2Glutathione Transferase (Glutathione S-Transferase)IBA
09/2021 - 12/2016
2dithiolIBA
09/2021 - 12/2016
2Metalloproteases (Metalloproteinases)IBA
10/2020 - 09/2020
2TamoxifenFDA LinkGeneric
01/2020 - 01/2014
2Estrogen ReceptorsIBA
01/2020 - 01/2014
2Glyoxal (Ethanedial)IBA
10/2019 - 11/2015
2MitogensIBA
08/2019 - 01/2019
2AntioxidantsIBA
01/2019 - 11/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 07/2014
2Protein Isoforms (Isoforms)IBA
01/2019 - 11/2013
2Cadherins (E-Cadherin)IBA
01/2019 - 07/2014
2Cyclin-Dependent Kinase Inhibitor p21IBA
01/2019 - 10/2011
2Iron Chelating AgentsIBA
01/2019 - 02/2014
2AdamantaneIBA
05/2018 - 02/2010
2SemicarbazonesIBA
05/2018 - 01/2015
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2016
2EnzymesIBA
01/2017 - 04/2014
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 08/2012
2Plasma GasesIBA
01/2017 - 01/2016
2Neoplasm Antigens (Tumor Antigens)IBA
04/2016 - 10/2004
2Transcription Factors (Transcription Factor)IBA
01/2016 - 03/2010
2Oxyhemoglobins (Oxyhemoglobin)IBA
01/2016 - 03/2014
2MethemoglobinIBA
01/2016 - 07/2012
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2015 - 03/2009
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2015 - 04/2014
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2015 - 06/2013
23-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
04/2014 - 12/2006

Therapy/Procedure

31Therapeutics
01/2022 - 01/2002
10Drug Therapy (Chemotherapy)
01/2022 - 05/2007
4Chelation Therapy (Therapy, Chelation)
11/2021 - 01/2003